|
Katie;
Just a thought.....you might consider using the Serum Her2 test on a regular basis. This might offer you some additional comfort regardless of what treatment you end up with. There's lots of information on the site about it. Here's Becky's explanation:
The Her2 Serum test measures the amount of "external domain" of the Her2 receptor in your blood. The external domain is the part that sticks out of the cancer cell on the outside - the part that Herceptin would latch onto. Theory is that the external domain is routinely shed. It ends up in the blood and can therefore be measured. So, if you have mets growing, the count would go up. However, what it is especially good for is if you have mets and are in treatment, you can get the test run and if the counts aren't going down, it is an indication the treatment is not working so it can cut down on scans just to see if the treatment is working.
If you search under Dr. Carney you will find lots of information. I know for instance that Gina uses it along with other tumor markers to moniter her metatastic disease. If the Serum Her2 is up she takes a loading dose of herceptin to stop any potential tumor build up. It has allowed her to use herceptin effectively for many years as her sole treatment. You are so young and have an aggressive, sneaky disease. It seems to me to offer you a way to monitor and potentially catch any spread very early on.
Cathy
__________________
Cathy
Diagnosed Oct. 2004 3 cm ductal, lumpectomy Nov. 2004
Diagnosed Jan. 2005 tumor in supraclavicular node
Stage 3c, Grade 3, ER/PR+, Her2++
4 AC, 4 Taxol, Radiation, Arimidex, Actonel
Herceptin for 9 months until Muga dropped and heart enlarged
Restarting herceptin weekly after 4 months off
Stopped herceptin after four weekly treatments....score dropped to 41
Finished 6 years Arimidex
May 2015 diagnosed with ovarian cancer
Stage 1C
started 6 treatments of carboplatin/taxol
Genetic testing show BRCA1 VUS
Nice! My hair came back really curly. Hope it lasts lol. Well it didn't but I liked it so I'm now a perm lady
29 March 2018 Lung biopsy following chest CT showing tumours in pleura of left lung, waiting for results to the question bc or ovarian
April 20, 2018 BC mets confirmed, ER/PR+ now Her2-
Questions about the possibility of ovarian spread and mets to bones so will be tested and monitored for these.
To begin new drug Palbociclib (Ibrance) along with Letrozole May, 2018.
Genetic testing of ovarian tumour and this new lung met will take months.
To see geneticist to be retested for BRCA this week....still BRCA VUS
CA125 has declined from 359 to 12 as of Aug.23/18
|